News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
SIECZKAREK MARK M
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/28/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/06/2019 |
4
| SIECZKAREK MARK M (Former Director and Officer) has filed a Form 4 on NovaBay Pharmaceuticals, Inc.|
Txns:
| Granted 167,938 shares
@ $0 |
|
| 06/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/26/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/02/2016 |
4
| SIECZKAREK MARK M (CEO) has filed a Form 4 on NovaBay Pharmaceuticals, Inc.|
Txns:
| Granted 261,780 shares
@ $1.91, valued at
$500k
Granted 130,890 warrants
@ $1.91, valued at
$250k
|
|
| 06/08/2016 |
4
| SIECZKAREK MARK M (CEO) has filed a Form 4 on NovaBay Pharmaceuticals, Inc.|
Txns:
| Granted 675,000 options to buy
@ $2.78, valued at
$1.9M
|
|
| 05/13/2016 |
4
| SIECZKAREK MARK M (Director) has filed a Form 4 on NovaBay Pharmaceuticals, Inc.|
Txns:
| Granted 130,890 warrants
@ $1.91, valued at
$250k
|
|
| 05/13/2016 |
4
| SIECZKAREK MARK M (Director) has filed a Form 4 on NovaBay Pharmaceuticals, Inc.|
Txns:
| Granted 261,780 shares
@ $1.91, valued at
$500k
|
|
| 03/09/2016 |
4
| SIECZKAREK MARK M (Director) has filed a Form 4 on NovaBay Pharmaceuticals, Inc.|
Txns:
| Granted 58,692 restricted stock units
@ $0 |
|
| 02/26/2016 |
4
| SIECZKAREK MARK M (Director) has filed a Form 4 on NovaBay Pharmaceuticals, Inc.|
Txns:
| Granted 125,387 shares
@ $1.91, valued at
$239.5k
|
|
| 01/06/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/16/2015 |
4
| SIECZKAREK MARK M (Director) has filed a Form 4 on NovaBay Pharmaceuticals, Inc.|
Txns:
| Granted 24,128 options to buy
@ $0.79, valued at
$19.1k
|
|
| 03/05/2015 |
4
| SIECZKAREK MARK M (Director) has filed a Form 4 on NovaBay Pharmaceuticals, Inc.|
Txns:
| Bought 166,666 shares
@ $0.6, valued at
$100k
Bought 166,666 options to buy
@ $0.6, valued at
$100k
Bought 124,999 options to buy
@ $0.65, valued at
$81.2k
|
|
| 01/06/2015 |
4
| SIECZKAREK MARK M (Director) has filed a Form 4 on NovaBay Pharmaceuticals, Inc.|
Txns:
| Granted 92,667 options to buy
@ $0.64, valued at
$59.3k
|
|
| 06/05/2014 |
4
| SIECZKAREK MARK M (Director) has filed a Form 4 on NovaBay Pharmaceuticals, Inc.|
Txns:
| Bought 4,800 shares
@ $0.89, valued at
$4.3k
|
|
| 05/21/2014 |
4
| SIECZKAREK MARK M (Director) has filed a Form 4 on NovaBay Pharmaceuticals, Inc.|
Txns:
| Bought 25,000 shares
@ $0.88, valued at
$22k
|
|
| 01/31/2014 |
4
| SIECZKAREK MARK M (Director) has filed a Form 4 on NovaBay Pharmaceuticals, Inc.|
Txns:
| Granted 33,567 options to buy
@ $1.14, valued at
$38.3k
|
|
| 01/27/2014 |
4
| SIECZKAREK MARK M (Interim Chairman/President/CEO) has filed a Form 4 on SOLTA MEDICAL INC|
Txns:
| Unknown transaction of 269,514 shares
@ $2.92, valued at
$787k
Disposed/sold 25,000 options to buy
@ $1.39, valued at
$34.8k
Disposed/sold 25,000 options to buy
@ $2.47, valued at
$61.8k
|
|
| 01/09/2014 |
4
| SIECZKAREK MARK M (Director) has filed a Form 4 on NovaBay Pharmaceuticals, Inc.|
Txns:
| Granted 30,000 options to buy
@ $1.25, valued at
$37.5k
|
|
| 01/02/2014 |
4
| SIECZKAREK MARK M (Interim Chairman/President/CEO) has filed a Form 4 on SOLTA MEDICAL INC|
Txns:
| Granted 7,710 shares
@ $0 |
|
| 12/03/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/04/2013 |
4
| SIECZKAREK MARK M (Interim Chairman/President/CEO) has filed a Form 4 on SOLTA MEDICAL INC|
Txns:
| Granted 7,579 shares
@ $0
Granted 9,151 shares
@ $0
Granted 9,461 shares
@ $0 |
|
| 06/07/2013 |
4
| SIECZKAREK MARK M (Director) has filed a Form 4 on SOLTA MEDICAL INC|
Txns:
| Granted 31,627 shares
@ $0 |
|
| 05/07/2013 |
4
| SIECZKAREK MARK M (Director) has filed a Form 4 on SOLTA MEDICAL INC|
Txns:
| Bought 150,000 shares
@ $1.74, valued at
$261k
|
|
| 06/11/2012 |
4
| SIECZKAREK MARK M (Director) has filed a Form 4 on SOLTA MEDICAL INC|
Txns:
| Granted 22,909 shares
@ $0 |
|
| 06/06/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/16/2011 |
4
| SIECZKAREK MARK M (President/CEO) has filed a Form 4 on CONCEPTUS INC|
Txns:
| Granted 10,000 shares
@ $0
Granted 75,000 rights
@ $13.2, valued at
$990k
|
|
| 06/07/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/01/2010 |
4
| SIECZKAREK MARK M (President/CEO) has filed a Form 4 on CONCEPTUS INC|
Txns:
| Granted 5,937 shares
@ $0
Granted 15,000 shares
@ $0
Granted 100,000 rights
@ $19.57, valued at
$2M
|
|
| 02/23/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/22/2010 |
4
| SIECZKAREK MARK M (President/CEO) has filed a Form 4 on CONCEPTUS INC|
Txns:
| Sold 98,311 shares
@ $20, valued at
$2M
Exercised 98,311 options to buy
@ $9.95, valued at
$978.2k
|
|
| 10/26/2009 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/25/2009 |
4
| SIECZKAREK MARK M (President/CEO) has filed a Form 4 on CONCEPTUS INC |
|
|
|